ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 171 filers reported holding ANIKA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $495,558 | -25.8% | 26,600 | +3.5% | 0.00% | 0.0% |
| Q2 2023 | $667,686 | +103.9% | 25,700 | +125.4% | 0.00% | +100.0% |
| Q1 2023 | $327,408 | -7.8% | 11,400 | -5.0% | 0.00% | 0.0% |
| Q4 2022 | $355,200 | -73.4% | 12,000 | -62.1% | 0.00% | -80.0% |
| Q3 2018 | $1,334,000 | +10.2% | 31,621 | -16.4% | 0.01% | 0.0% |
| Q2 2018 | $1,210,000 | +120.8% | 37,816 | +243.4% | 0.01% | +66.7% |
| Q1 2018 | $548,000 | – | 11,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
| CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
| AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
| Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
| Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
| Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
| DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
| THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
| NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
| Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |